share_log

B of A Securities Maintains Neutral on Novavax, Raises Price Target to $18

Benzinga ·  Jun 14 13:27

B of A Securities analyst Alec Stranahan maintains Novavax (NASDAQ:NVAX) with a Neutral and raises the price target from $12 to $18.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment